TEHRAN, Dec. 30 (MNA) – Researchers in the Mashhad University of Medical Sciences Center for Genetic Research has developed a new method for treating gastrointestinal cancers.
Dr. Mohammad Reza Abbaszadegan, the project senior researcher told Mehr News that the research was carried out on factors contributing to esophagus cancer. “The method works through molecular interventions of the factors,” he said. “We examined two factors of somatic cells (specifically esophagus epithelial cells), which would turn into fundamental malignant tumors,” he added, “The study was carried out on a sample population of patients diagnosed with esophagus cancer.”
“We found that a high percent of patients had the factor, including Mastermind and Twist 1 factors,” he said. “The second phase of the research would examine whether this method would stop the growth of cancer cells, where we found some success,” said the senior researcher.
The head of Mashhad University of Medical Sciences Center for Genetic Research also pointed to the side-effects of non-specific treatment such as chemotherapy and radiotherapy. “General strands of treatment have side-effects on patients, while the preset method is a specifically biological method,” he said.
“The research findings would find applications in the treatment of larger intestine cancers,” he added.
The Iran Project is not responsible for the content of quoted articles.